Nyxoah S.A. (NYXH) Stock Ticker
NYXH right now
Market factors today
Unlock the full NYXH picture
About Nyxoah S.A.
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
NYXH stock facts
| Ticker symbol | NYXH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| Market cap | $145.1M |
| CEO | Olivier Taelman |
| Employees | 154 |
| Headquarters | Mont-Saint-Guibert, WA, BE |
| IPO date | 2021-04-28 |
| Website | www.nyxoah.com |
What you can see for NYXH on Tickr
Live NYXH price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the NYXH report.
Rankings
FAQ
What is the ticker symbol for Nyxoah S.A.?
The ticker symbol for Nyxoah S.A. is NYXH, listed on the NASDAQ.
What is NYXH?
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert,…